SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Krista Raymer talks the changing landscape of cannabis retail in Ontario

    By

    On this episode – BofC Live features a conversation with Krista Raymer, Co-Founder of Vetrina Group – a retail consultancy with an emphasis on cannabis retail. This is the fourth in a series of conversations with the team from Vetrina Group as we take a deep look at the future of cannabis retail. In this conversation, Raymer will dive into the key attributes of hiring a store manager for a cannabis retail store – and how those attributes have changed over time. Raymer is joined by Lisa Bigoni who was a round 1 cannabis retail lottery winner in Ontario – and subsequently opened Choom in Niagara Falls. Now, Bigoni is in the process of opening a number of cannabis retail stores in Scarborough, Ontario.

    Lisa Bigioni noted:

    It’s a serious business. It’s not just selling weed. It’s serving customers who are nervous about going into a store. I’ve had friends say, “Will you please come in with me? Because I don’t know what to expect.” People are nervous to go into the store and especially with this additional layer of COVID, there’s: How am I going to be received? Are they going to be wearing masks? Am I going to have to touch anything? So we really do have to treat it like it is a very serious business and we’re doing some really good work and some really good things for our customers who are looking for it. It’s all part of that big picture. – Lisa Bigioni, Stok’d

    Listen to this BofC Live via podcast:

    BofC

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free